Cargando…
Late-Onset Neutropenia after Rituximab Treatment for Adult-Onset Nephrotic Syndrome
A 41-year-old woman developed nephrotic syndrome at the age of 32 and was diagnosed with minimal change nephrotic syndrome based on a renal biopsy. Although remission was achieved with administration of prednisolone (PSL) and cyclosporine, the nephrotic syndrome recurred. She was also started on rit...
Autores principales: | Yamazaki, Mayuko, Sugiura, Hidekazu, Iwatani, Yosuke, Kyoda, Mizuki, Nokiba, Hirohiko, Amemiya, Nobuyuki, Nitta, Kosaku, Tsuchiya, Ken |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425356/ https://www.ncbi.nlm.nih.gov/pubmed/30956827 http://dx.doi.org/10.1155/2019/3580941 |
Ejemplares similares
-
Three cases of late-onset oligomeganephronia
por: Kawanishi, Kunio, et al.
Publicado: (2011) -
Comparison of the response of frequently relapsing steroid-dependent minimal change nephrotic syndrome to rituximab therapy between childhood-onset and adult-onset disease
por: Iwabuchi, Yuko, et al.
Publicado: (2018) -
The role of BAFF and G-CSF for rituximab-induced late-onset neutropenia (LON) in lymphomas
por: Tesfa, Daniel, et al.
Publicado: (2021) -
Rituximab-Related Late-Onset Neutropenia in Patients with Rheumatic Diseases: Successful Re-Challenge of the Treatment
por: Reitblat, Tatiana, et al.
Publicado: (2015) -
A case of late-onset neutropenia secondary to rituximab in a patient with mucous membrane pemphigoid
por: Schultz, Brittney, et al.
Publicado: (2019)